Iovance Biotherapeutics Inc to Discuss Clinical Data for LN-145 in Non-Small Cell Lung Cancer- Conference Call Summary - Thomson StreetEvents

Iovance Biotherapeutics Inc to Discuss Clinical Data for LN-145 in Non-Small Cell Lung Cancer- Conference Call Summary

Iovance Biotherapeutics Inc to Discuss Clinical Data for LN-145 in Non-Small Cell Lung Cancer- Conference Call Summary - Thomson StreetEvents
Iovance Biotherapeutics Inc to Discuss Clinical Data for LN-145 in Non-Small Cell Lung Cancer- Conference Call Summary
Published Jun 29, 2021
17 pages (8288 words) — Published Jun 29, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of IOVA.OQ conference call or presentation 29-Jun-21 8:30pm GMT

  
Brief Excerpt:

...A. Exciting Initial Clinical Data for TIL Therapy: Exciting initial clinical data for TIL therapy in non-small cell lung cancer. 1....

  
Report Type:

Brief

Source:
Company:
Iovance Biotherapeutics Inc
Ticker
IOVA.OQ
Time
8:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Iovance Biotherapeutics Inc Q3 2021 Earnings Call Summary – 2021-11-04 – US$ 54.00 – Edited Brief of IOVA.OQ earnings conference call or presentation 4-Nov-21 8:30pm GMT

Iovance Biotherapeutics Inc Q3 2021 Earnings Call Transcript – 2021-11-04 – US$ 54.00 – Edited Transcript of IOVA.OQ earnings conference call or presentation 4-Nov-21 8:30pm GMT

Iovance Biotherapeutics Inc Q2 2021 Earnings Call Summary – 2021-08-05 – US$ 54.00 – Edited Brief of IOVA.OQ earnings conference call or presentation 5-Aug-21 8:30pm GMT

Iovance Biotherapeutics Inc Q2 2021 Earnings Call Transcript – 2021-08-05 – US$ 54.00 – Edited Transcript of IOVA.OQ earnings conference call or presentation 5-Aug-21 8:30pm GMT

Iovance Biotherapeutics Inc to Discuss Clinical Data for LN-145 in Non-Small Cell Lung Cancer- Conference Call Transcript – 2021-06-29 – US$ 54.00 – Edited Transcript of IOVA.OQ conference call or presentation 29-Jun-21 8:30pm GMT

Iovance Biotherapeutics Inc at JMP Securities Life Sciences Virtual Conference Transcript – 2021-06-17 – US$ 54.00 – Edited Transcript of IOVA.OQ presentation 17-Jun-21 6:00pm GMT

Iovance Biotherapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript – 2021-06-09 – US$ 54.00 – Edited Transcript of IOVA.OQ presentation 9-Jun-21 9:30pm GMT

Iovance Biotherapeutics Inc to Discuss Clinical Data for Lifileucel at ASCO Transcript – 2021-06-06 – US$ 54.00 – Edited Transcript of IOVA.OQ corporate analyst meeting</ 6-Jun-21 4:00pm GMT

Iovance Biotherapeutics Inc at Jefferies Healthcare Conference (Virtual) Transcript – 2021-06-01 – US$ 54.00 – Edited Transcript of IOVA.OQ presentation 1-Jun-21 7:30pm GMT

Iovance Biotherapeutics Inc Q1 2021 Earnings Call Summary – 2021-05-06 – US$ 54.00 – Edited Brief of IOVA.OQ earnings conference call or presentation 6-May-21 8:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Iovance Biotherapeutics Inc to Discuss Clinical Data for LN-145 in Non-Small Cell Lung Cancer- Conference Call Summary" Jun 29, 2021. Alacra Store. Apr 29, 2024. <http://www.alacrastore.com/thomson-streetevents-transcripts/Iovance-Biotherapeutics-Inc-to-Discuss-Clinical-Data-for-LN-145-in-Non-Small-Cell-Lung-Cancer-Conference-Call-B14913497>
  
APA:
Thomson StreetEvents. (2021). Iovance Biotherapeutics Inc to Discuss Clinical Data for LN-145 in Non-Small Cell Lung Cancer- Conference Call Summary Jun 29, 2021. New York, NY: Alacra Store. Retrieved Apr 29, 2024 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Iovance-Biotherapeutics-Inc-to-Discuss-Clinical-Data-for-LN-145-in-Non-Small-Cell-Lung-Cancer-Conference-Call-B14913497>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.